KPTI logo

Karyopharm Therapeutics (KPTI) Accounts Receivable

Annual Accounts Receivable

$30.77 M
+$3.80 M+14.11%

December 31, 2024


Summary


Performance

KPTI Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPTIbalance sheetmetrics:

Quarterly Accounts Receivable

$30.77 M
-$1.01 M-3.18%

December 31, 2024


Summary


Performance

KPTI Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPTIbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

KPTI Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.1%0.0%
3 y3 years+36.8%0.0%
5 y5 years+291.3%0.0%

KPTI Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.7%+36.8%-34.7%+36.8%
5 y5-year-34.7%+291.3%-34.7%+291.3%
alltimeall time-34.7%-100.0%-34.7%-100.0%

Karyopharm Therapeutics Accounts Receivable History

DateAnnualQuarterly
Dec 2024
$30.77 M(+14.1%)
$30.77 M(-3.2%)
Sep 2024
-
$31.78 M(-16.4%)
Jun 2024
-
$37.99 M(+22.2%)
Mar 2024
-
$31.08 M(+15.3%)
Dec 2023
$26.96 M(-42.7%)
$26.96 M(-28.9%)
Sep 2023
-
$37.92 M(+17.5%)
Jun 2023
-
$32.28 M(-8.3%)
Mar 2023
-
$35.20 M(-25.2%)
Dec 2022
$47.09 M
$47.09 M(+71.6%)
Sep 2022
-
$27.45 M(+16.9%)
Jun 2022
-
$23.48 M(-6.1%)
DateAnnualQuarterly
Mar 2022
-
$24.99 M(+11.1%)
Dec 2021
$22.50 M(+74.7%)
$22.50 M(+20.0%)
Sep 2021
-
$18.75 M(+4.8%)
Jun 2021
-
$17.89 M(+0.2%)
Mar 2021
-
$17.84 M(+38.5%)
Dec 2020
$12.88 M(+63.8%)
$12.88 M(+16.4%)
Sep 2020
-
$11.06 M(+15.5%)
Jun 2020
-
$9.58 M(+3.2%)
Mar 2020
-
$9.28 M(+18.0%)
Dec 2019
$7.86 M(>+9900.0%)
$7.86 M(-0.8%)
Sep 2019
-
$7.93 M(>+9900.0%)
Dec 2018
$0.00
$0.00

FAQ

  • What is Karyopharm Therapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics annual accounts receivable year-on-year change?
  • What is Karyopharm Therapeutics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics quarterly accounts receivable year-on-year change?

What is Karyopharm Therapeutics annual accounts receivable?

The current annual accounts receivable of KPTI is $30.77 M

What is the all time high annual accounts receivable for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high annual accounts receivable is $47.09 M

What is Karyopharm Therapeutics annual accounts receivable year-on-year change?

Over the past year, KPTI annual accounts receivable has changed by +$3.80 M (+14.11%)

What is Karyopharm Therapeutics quarterly accounts receivable?

The current quarterly accounts receivable of KPTI is $30.77 M

What is the all time high quarterly accounts receivable for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high quarterly accounts receivable is $47.09 M

What is Karyopharm Therapeutics quarterly accounts receivable year-on-year change?

Over the past year, KPTI quarterly accounts receivable has changed by $0.00 (0.00%)